SCHEMBL29663229

SCHEMBL29663229

CCOC(=O)c1cn([C@@H](C)CF)cn1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NOTUM Q6P988 1/20 0.45
▸ CYP1A2 P05177 1/20 0.41
▸ KDM4E B2RXH2 2/20 0.40
▸ ALDH1A1 P00352 2/20 0.40
▸ HPGD P15428 1/20 0.40
▸ GAA P10253 1/20 0.38
▸ GABRA2 P47869 3/20 0.38
▸ GABRB2 P47870 3/20 0.38
▸ POLB P06746 1/20 0.37
▸ MLYCD O95822 1/20 0.37
▸ LMNA P02545 2/20 0.36
▸ GABRP O00591 1/20 0.36
▸ GABRD O14764 1/20 0.36
▸ GABRA1 P14867 1/20 0.36
▸ GABRB1 P18505 1/20 0.36
▸ GABRG2 P18507 1/20 0.36
▸ GABRB3 P28472 1/20 0.36
▸ GABRA5 P31644 1/20 0.36
▸ GABRA3 P34903 1/20 0.36
▸ GABRA4 P48169 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29663383 1.00 NOTUM (0.45) NOTUMCYP1A2KDM4EALDH1A1HPGD
SCHEMBL29663384 1.00 NOTUM (0.45) NOTUMCYP1A2KDM4EALDH1A1HPGD
SCHEMBL17750114 0.88 NOTUM (0.47) NOTUMCYP1A2KDM4EALDH1A1HPGD
SCHEMBL29215881 0.88 NOTUM (0.47) NOTUMCYP1A2KDM4EALDH1A1HPGD
SCHEMBL21026472 0.88 NOTUM (0.47) NOTUMCYP1A2KDM4EALDH1A1HPGD
SCHEMBL29215889 0.88 NOTUM (0.47) NOTUMCYP1A2KDM4EALDH1A1HPGD
SCHEMBL15148626 0.88 NOTUM (0.47) NOTUMCYP1A2KDM4EALDH1A1HPGD
SCHEMBL15148680 0.88 NOTUM (0.47) NOTUMCYP1A2KDM4EALDH1A1HPGD
SCHEMBL29215897 0.87 NOTUM (0.46) NOTUMCYP1A2KDM4EALDH1A1HPGD
SCHEMBL29215901 0.87 NOTUM (0.46) NOTUMCYP1A2KDM4EALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220289751-A1 COMPOUND HAVING KDM5 INHIBITORY ACTIVITY AND PHARMACEUTICAL USE THEREOF ONO PHARMACEUTICAL CO., LTD. (JP) 2022-09-15 — — US disclosed
EP-3999183-A1 COMPOUND HAVING KDM5 INHIBITORY ACTIVITY AND PHARMACEUTICAL USE THEREOF Ono Pharmaceutical Co., Ltd. (JP) 2022-05-25 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220289751-A1 COMPOUND HAVING KDM5 INHIBITORY ACTIVITY AND PHARMACEUTICAL USE THEREOF KDM5A, KDM1B, KDM5D NOTUM 1558/4885CYP1A2 4359/4885KDM4E 16/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback